SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-044410
Filing Date
2024-04-15
Accepted
2024-04-15 16:09:29
Documents
3
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A ikt-proxy-2024_pre_14a.htm PRE 14A 753893
2 GRAPHIC img232614365_0.jpg GRAPHIC 80488
3 GRAPHIC img232614365_1.jpg GRAPHIC 494412
  Complete submission text file 0000950170-24-044410.txt   1542579
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39676 | Film No.: 24844739
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)